DK1083879T3 - Indretninger til at tilvejebringe forlænget medikamentterapi - Google Patents
Indretninger til at tilvejebringe forlænget medikamentterapiInfo
- Publication number
- DK1083879T3 DK1083879T3 DK99955212T DK99955212T DK1083879T3 DK 1083879 T3 DK1083879 T3 DK 1083879T3 DK 99955212 T DK99955212 T DK 99955212T DK 99955212 T DK99955212 T DK 99955212T DK 1083879 T3 DK1083879 T3 DK 1083879T3
- Authority
- DK
- Denmark
- Prior art keywords
- devices
- drug therapy
- providing extended
- extended drug
- drug
- Prior art date
Links
- 238000002651 drug therapy Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000001174 ascending effect Effects 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
- G01N21/9508—Capsules; Tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8778798P | 1998-06-03 | 1998-06-03 | |
| US09/253,317 US6919373B1 (en) | 1996-11-12 | 1999-02-19 | Methods and devices for providing prolonged drug therapy |
| EP99955212A EP1083879B1 (en) | 1998-06-03 | 1999-05-27 | Devices for providing prolonged drug therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1083879T3 true DK1083879T3 (da) | 2005-01-31 |
Family
ID=26777397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99955212T DK1083879T3 (da) | 1998-06-03 | 1999-05-27 | Indretninger til at tilvejebringe forlænget medikamentterapi |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1449524A1 (https=) |
| JP (1) | JP2002516848A (https=) |
| KR (1) | KR20080083074A (https=) |
| CN (1) | CN1209098C (https=) |
| AT (1) | ATE277594T1 (https=) |
| AU (1) | AU4319799A (https=) |
| CA (1) | CA2333688A1 (https=) |
| DE (1) | DE69920689T2 (https=) |
| DK (1) | DK1083879T3 (https=) |
| ES (1) | ES2229783T3 (https=) |
| HK (1) | HK1046638B (https=) |
| IL (1) | IL140020A0 (https=) |
| NO (1) | NO330235B1 (https=) |
| NZ (1) | NZ508567A (https=) |
| PT (1) | PT1083879E (https=) |
| WO (1) | WO1999062496A1 (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| MXPA01004381A (es) | 1998-11-02 | 2005-09-08 | Elan Corp Plc | Composicion de multiparticulado de liberacion modificada. |
| US7083808B2 (en) | 1998-12-17 | 2006-08-01 | Euro-Celtique S.A. | Controlled/modified release oral methylphenidate formulations |
| US6419960B1 (en) | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| US6673367B1 (en) | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
| IL150657A0 (en) * | 2000-01-20 | 2003-02-12 | Delsys Pharmaceutical Corp | Multi-step drug dosage forms |
| AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
| US20020187192A1 (en) * | 2001-04-30 | 2002-12-12 | Yatindra Joshi | Pharmaceutical composition which reduces or eliminates drug abuse potential |
| US20030049272A1 (en) * | 2001-08-30 | 2003-03-13 | Yatindra Joshi | Pharmaceutical composition which produces irritation |
| US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
| NZ532096A (en) | 2001-09-28 | 2006-10-27 | Mcneil Ppc Inc | Dosage forms having an inner core and outer shell with different shapes |
| US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| NZ570198A (en) * | 2002-07-29 | 2010-01-29 | Alza Corp | Methods and dosage forms for controlled delivery of paliperidone or risperidone |
| KR100995486B1 (ko) * | 2002-09-28 | 2010-11-22 | 맥네일-피피씨, 인코포레이티드 | 개구가 있는 쉘을 포함하는 속방성 투여형 |
| GR1004330B (el) * | 2002-10-14 | 2003-09-05 | Lavipharm A.E. | Φαρμακοτεχνικη μορφη για τη χορηγηση οργανικων νιτρικων ενωσεων |
| US7988993B2 (en) | 2002-12-09 | 2011-08-02 | Andrx Pharmaceuticals, Inc. | Oral controlled release dosage form |
| US20040197407A1 (en) * | 2003-02-11 | 2004-10-07 | Ramkumar Subramanian | Methods and dosage forms with modified layer geometry |
| CA2540308C (en) | 2003-09-26 | 2013-08-06 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
| CN1867359B (zh) * | 2003-10-08 | 2010-12-15 | 马林克罗特公司 | 哌甲酯溶液及其制药用途和制备方法 |
| US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
| AU2005245025B2 (en) * | 2004-05-21 | 2010-06-03 | Accu-Break Technologies, Inc. | Pharmaceutical tablets comprising two or more unitary segments |
| ES2261006B1 (es) * | 2004-06-10 | 2007-11-01 | Laboratorios Rubio, S.A. | Pellet multicapa de liberacion controlada de metilfenidato. |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| WO2006046114A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Osmotic dosage forms providing ascending drug release, and processes for their preparation |
| WO2009023006A2 (en) * | 2006-05-08 | 2009-02-19 | Mcneil-Ppc, Inc. | Modified release dosage form |
| US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
| PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
| FR2899476B1 (fr) * | 2006-04-11 | 2008-07-04 | Assist Publ Hopitaux De Paris | Association du mazindol dans le traitement du deficit de l'attention/hyperactivite |
| US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
| WO2010053306A2 (ko) * | 2008-11-07 | 2010-05-14 | 주식회사 삼양사 | 메칠페니데이트의 방출 제어용 약제학적 조성물 |
| WO2011071877A2 (en) | 2009-12-07 | 2011-06-16 | Mcneil-Ppc, Inc. | Partial dip coating of dosage forms for modified release |
| UY34856A (es) * | 2012-07-03 | 2013-12-31 | Bayer Pharma AG | Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida |
| WO2014174388A1 (en) * | 2013-03-29 | 2014-10-30 | Wockhardt Limited | Modified release pharmaceutical compositions of methylphenidate or salts thereof |
| CA2936740C (en) | 2014-10-31 | 2017-10-10 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US9707217B1 (en) | 2017-02-03 | 2017-07-18 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dose-dumping resistant controlled release dosage form |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| KR20210119458A (ko) * | 2019-01-25 | 2021-10-05 | 아이언쇼어 파마슈티컬즈 앤드 디벨롭먼트, 인크. | 주의력 결핍 과잉행동 장애의 치료를 위한 메틸페니데이트 조성물 |
| CA3130379A1 (en) * | 2019-03-05 | 2020-09-10 | Kashiv Biosciences, Llc | Delayed release methylphenidate compositions |
| CN114681422B (zh) * | 2020-12-30 | 2023-09-05 | 深圳翰宇药业股份有限公司 | 一种硝苯地平控释片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
| HUT77530A (hu) * | 1994-05-06 | 1998-05-28 | Pfizer Inc. | Azitromicint tartalmazó, szabályozott hatóanyag-felszabadítású dózisformák |
| US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| AU3909597A (en) * | 1996-08-16 | 1998-03-06 | Alza Corporation | Dosage form for providing ascending dose of drug |
| CA2264852C (en) * | 1996-09-30 | 2005-11-01 | Alza Corporation | Use of methylphenidate or a pharmaceutically acceptable salt thereof |
-
1999
- 1999-05-27 AT AT99955212T patent/ATE277594T1/de active
- 1999-05-27 PT PT99955212T patent/PT1083879E/pt unknown
- 1999-05-27 CA CA002333688A patent/CA2333688A1/en not_active Abandoned
- 1999-05-27 CN CNB998069701A patent/CN1209098C/zh not_active Expired - Lifetime
- 1999-05-27 NZ NZ508567A patent/NZ508567A/xx not_active IP Right Cessation
- 1999-05-27 IL IL14002099A patent/IL140020A0/xx unknown
- 1999-05-27 DK DK99955212T patent/DK1083879T3/da active
- 1999-05-27 JP JP2000551752A patent/JP2002516848A/ja not_active Withdrawn
- 1999-05-27 HK HK02108159.8A patent/HK1046638B/zh not_active IP Right Cessation
- 1999-05-27 WO PCT/US1999/011920 patent/WO1999062496A1/en not_active Ceased
- 1999-05-27 EP EP04075594A patent/EP1449524A1/en not_active Withdrawn
- 1999-05-27 EP EP99955212A patent/EP1083879B1/en not_active Expired - Lifetime
- 1999-05-27 ES ES99955212T patent/ES2229783T3/es not_active Expired - Lifetime
- 1999-05-27 DE DE69920689T patent/DE69920689T2/de not_active Expired - Lifetime
- 1999-05-27 KR KR1020087021536A patent/KR20080083074A/ko not_active Ceased
- 1999-05-27 AU AU43197/99A patent/AU4319799A/en not_active Abandoned
-
2000
- 2000-11-28 NO NO20006007A patent/NO330235B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2333688A1 (en) | 1999-12-09 |
| HK1046638A1 (en) | 2003-01-24 |
| CN1209098C (zh) | 2005-07-06 |
| NO20006007L (no) | 2001-02-05 |
| EP1083879B1 (en) | 2004-09-29 |
| NO20006007D0 (no) | 2000-11-28 |
| NO330235B1 (no) | 2011-03-07 |
| HK1035492A1 (en) | 2001-11-30 |
| ES2229783T3 (es) | 2005-04-16 |
| AU4319799A (en) | 1999-12-20 |
| WO1999062496A1 (en) | 1999-12-09 |
| KR20080083074A (ko) | 2008-09-12 |
| JP2002516848A (ja) | 2002-06-11 |
| DE69920689T2 (de) | 2005-02-24 |
| ATE277594T1 (de) | 2004-10-15 |
| EP1083879A1 (en) | 2001-03-21 |
| NZ508567A (en) | 2004-02-27 |
| EP1449524A1 (en) | 2004-08-25 |
| PT1083879E (pt) | 2005-01-31 |
| DE69920689D1 (de) | 2004-11-04 |
| HK1046638B (zh) | 2006-02-24 |
| CN1352549A (zh) | 2002-06-05 |
| IL140020A0 (en) | 2002-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1083879T3 (da) | Indretninger til at tilvejebringe forlænget medikamentterapi | |
| NO20053224D0 (no) | Patient controlled drug administration device. | |
| CY1112260T1 (el) | Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης | |
| DK1001772T3 (da) | Forbedret afgivelse af flere doser af et medikament | |
| NO971206D0 (no) | Forlenget-frigjöringsformulering | |
| EP1509278A4 (en) | IMPLANTABLE MEDICAMENT DELIVERY DEVICE | |
| ATE359077T1 (de) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
| EP1566174A3 (en) | Flash-melt oral dosage formulation | |
| CY1106072T1 (el) | Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος | |
| IS6892A (is) | Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn | |
| ATE274902T1 (de) | Pharmazeutische dosierungsformen zur kontrollierter pulsierender abgabe | |
| DK0841903T3 (da) | Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol | |
| HRP20041152B1 (hr) | Farmaceutske formulacije | |
| IS7076A (is) | Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni | |
| ZA200405657B (en) | Formulation & dosage form for the controlled delivery of therapeutic agents. | |
| NO308854B1 (no) | Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav | |
| EP1514105A4 (en) | METHODS FOR MODULATING THE ACTIVITY OF TUBULIN DEACETYLASE | |
| ATE312621T1 (de) | Pharmazeutische formulierungen von thyroidhormonen | |
| NO20101070L (no) | Fremgangsmate til dosering av et medikament, samt doseringsform | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| FI20000780L (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| NO20002526L (no) | Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav |